StockData
CVS HEALTH Corp logo

CVS HEALTH Corp (CVS) stock

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3015% above fair value
$88.59−0.76 (-0.85%)

Close on Nov 16, 2026Market cap $113.30BP/E 23.5Yield 3.00%

Cvs Health total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Cvs Health's total debt was $61.41B at Jun 30, 2026. For fiscal 2025 it was $64.57B, down 2.6% from the year before. Over ten years it grew 8.9% a year on average. The highest annual figure on record is $73.43B in fiscal 2018.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$64.57B-2.6%
FY2024Dec 31, 2024$66.27B+7.6%
FY2023Dec 31, 2023$61.61B+17.9%
FY2022Dec 31, 2022$52.25B-7.0%
FY2021Dec 31, 2021$56.18B-13.1%
FY2020Dec 31, 2020$64.65B-5.6%
FY2019Dec 31, 2019$68.48B-6.7%
FY2018Dec 31, 2018$73.43B+171.9%
FY2017Dec 31, 2017$27.00B-1.9%
FY2016Dec 31, 2016$27.53B+0.2%
FY2015Dec 31, 2015$27.46B+113.1%
FY2014Dec 31, 2014$12.89B-3.8%
FY2013Dec 31, 2013$13.40B+36.4%
FY2012Dec 31, 2012$9.83B-1.9%
FY2011Dec 31, 2011$10.01B-0.4%
FY2010Dec 31, 2010$10.06B-10.0%
FY2009Dec 31, 2009$11.18B-4.9%
FY2008Dec 31, 2008$11.75B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$61.41B-7.6%
Q1 FY2026Mar 31, 2026$63.11B-2.5%
Q4 FY2025Dec 31, 2025$64.57B-2.6%
Q3 FY2025Sep 30, 2025$65.84B+0.5%
Q2 FY2025Jun 30, 2025$66.49B+0.2%
Q1 FY2025Mar 31, 2025$64.71B+0.9%
Q4 FY2024Dec 31, 2024$66.27B+7.6%
Q3 FY2024Sep 30, 2024$65.53B+5.8%
Q2 FY2024Jun 30, 2024$66.37B+4.0%
Q1 FY2024Mar 31, 2024$64.14B+10.2%
Q4 FY2023Dec 31, 2023$61.61B+17.9%
Q3 FY2023Sep 30, 2023$61.91B+18.6%
Q2 FY2023Jun 30, 2023$63.82B+16.4%
Q1 FY2023Mar 31, 2023$58.23B+3.5%
Q4 FY2022Dec 31, 2022$52.25B-7.0%
Q3 FY2022Sep 30, 2022$52.21B-10.6%
Q2 FY2022Jun 30, 2022$54.82B-7.6%
Q1 FY2022Mar 31, 2022$56.28B-9.1%
Q4 FY2021Dec 31, 2021$56.18B-13.1%
Q3 FY2021Sep 30, 2021$58.39B-12.8%
Q2 FY2021Jun 30, 2021$59.35B-17.2%
Q1 FY2021Mar 31, 2021$61.94B-13.7%
Q4 FY2020Dec 31, 2020$64.65B-5.6%
Q3 FY2020Sep 30, 2020$67.00B-3.0%
Q2 FY2020Jun 30, 2020$71.67B+0.5%
Q1 FY2020Mar 31, 2020$71.82B-4.0%
Q4 FY2019Dec 31, 2019$68.48B-6.7%
Q3 FY2019Sep 30, 2019$69.05B+9.8%
Q2 FY2019Jun 30, 2019$71.28B+9.5%
Q1 FY2019Mar 31, 2019$74.79B+14.9%
Q4 FY2018Dec 31, 2018$73.43B+171.9%
Q3 FY2018Sep 30, 2018$62.89B+143.8%
Q2 FY2018Jun 30, 2018$65.11B+143.3%
Q1 FY2018Mar 31, 2018$65.09B+137.3%
Q4 FY2017Dec 31, 2017$27.00B-1.9%
Q3 FY2017Sep 30, 2017$25.79B+7485.0%
Q2 FY2017Jun 30, 2017$26.76B–
Q1 FY2017Mar 31, 2017$27.43B–
Q4 FY2016Dec 31, 2016$27.53B–
Q3 FY2016Sep 30, 2016$340.00M–

More Cvs Health figures

See a number that looks wrong?